$CME

CME Group 3Q Profit, Revenue Rise on Higher Derivatives Volume

CME Group reported Q3 net income of $1.04B ($2.89/share), up from $908M ($2.49/share) YoY. Revenue rose to $1.74B, beating estimates. ADV increased to 29.4M contracts. CEO Terry Duffy plans to step down early next year, with Lynne Fitzpatrick succeeding him.

Original reporting
Published Oct 21, 2026, 11:51 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 12:03 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CME
Bullish
high confidence
Mentioned
$CME
Relevance
8/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$CMEBullishHigh
01

Why it matters

Earnings beat and volume growth suggest short‑term bullish pressure, but leadership change adds uncertainty.

02

Market read

CME's earnings beat and rising trading volumes provide a positive catalyst for the exchange sector, while the upcoming leadership transition may temper enthusiasm.

03

What to watch

The announced CEO succession and cloud‑migration progress could introduce execution risk not reflected in the earnings numbers.

Relevance 8/10Novelty 8/10Timing: after‑hours release

Background

CME Group is the world’s largest derivatives exchange, reporting Q3 2026 results.

Company-level read

Ticker impact

$CMEBullishHigh confidence
Context

CME Group posted Q3 net income of $1.04 billion and revenue of $1.74 billion, both ahead of analysts' estimates.

Expected impact

likely modest upside as market prices in the earnings beat and volume growth

Evidence & confidence

The beat over consensus and 20% rise in market‑data revenue indicate stronger demand for CME's services, supporting a short‑term price lift.

Market effects

Positive earnings may boost sentiment for the broader exchange and derivatives sector.

U.S. market participants may view CME's results as a sign of resilient trading activity amid market uncertainty.

CME's global clearing and data services could influence international trading volumes.

Counterpoint

The modest beat may already be priced in; investors could be cautious given higher operating costs and upcoming CEO transition.

Key entities

  • CME Group

    Global derivatives exchange operator.

  • Terry Duffy

    Outgoing CEO, stepping down early next year.

  • Lynne Fitzpatrick

    Current CFO, designated successor as CEO.

Related articles

$CMEHighAI 8/10

CME: 3Q 2026 Intro Script

CME Group reported record Q3 2026 earnings with $1.7B revenue (up 13% YoY) and $3.02 EPS (up 13% YoY). ADV reached 29.4M contracts (up 16% YoY), with strong growth across all asset classes. Open interest hit 128M contracts, and international volume grew 22%. The company launched new products and plans to migrate markets to Google Cloud by late 2027.

$CMEHighAI 9/10

CME: 3Q 2026 Income Statement Trend

CME Group Inc. reported financial data for Q3 2026, showing total revenues of $1,737.3 million and net income of $1,036.9 million. Operating income was $1,141.4 million with an operating margin of 66%. Basic and diluted EPS were $2.90 and $2.89 respectively.

$CMEMed

CME Group (CME) Shares Slip Despite Strong Q3 Results; Dividend

CME Group (CME) shares fell 1.2% premarket despite Q3 earnings and revenue beating estimates. Adjusted EPS was $3.02 on revenue of $1.74B, but expenses rose to $595.9M. The dividend yield is 4.04% with a high payout ratio of 95% and negative 3-year dividend growth. CME's GF Score is 88/100, indicating strong fundamentals but financial strength concerns.